Ten-Year Outcomes of Children and Adolescents Who Underwent Sleeve Gastrectomy: Weight Loss, Comorbidity Resolution, Adverse Events, and Growth Velocity
Topic overview
Ten-year prospective study of 2,504 children/adolescents undergoing laparoscopic sleeve gastrectomy shows sustained weight loss (71% excess weight lost at 7-10 years), high comorbidity remission rates for diabetes and hypertension, normal growth velocity, and low adverse event rate (1%). Demonstrates LSG durability and safety in pediatric severe obesity beyond typical 5-year follow-up.
Key takeaways
- Sleeve gastrectomy in youth achieves durable weight loss: 82% excess weight lost at 1-3 years, 71% maintained at 7-10 years post-op.
- Comorbidity remission sustained long-term: 74% T2DM resolution, 59% dyslipidemia, 64% hypertension at 7-10 year follow-up.
- Growth velocity unaffected by LSG in pediatric patients, with height z-scores remaining stable across 10-year follow-up period.
- Low adverse event rate (1%) with zero procedure-related mortality in cohort of 2,504 children/adolescents undergoing LSG.
- LSG demonstrates superior durability compared to lifestyle interventions alone for severe pediatric obesity (class II/III).
Comments